Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic

Overview of attention for article published in Cancer Management and Research, January 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,424 followers.

Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic. #lymphoma #lymsm https://t.co/WnuJi7ojI6

New article: Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic. https://t.co/Wxk5zPahUi #FL #lymsm #hematology https://t.co/27tHHpktfq

[Full text] Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility a | CMAR - Dove Medical Press https://t.co/XpGyeaeBtK